|
Tomita, Naruya; Kim, John Y S; Gibbons, Gary H et al. (2004) Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis. Int J Mol Med 13:629-36
|
|
Akishita, M; Shirakami, G; Iwai, M et al. (2001) Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice. J Hypertens 19:1083-8
|
|
Daviet, L; Lehtonen, J Y; Hayashida, W et al. (2001) Intracellular third loops in AT1 and AT2 receptors determine subtype specificity. Life Sci 69:509-16
|
|
Tomita, N; Morishita, R; Tomita, S et al. (2000) Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo. Gene Ther 7:1326-32
|
|
Horiuchi, M; Hayashida, W; Akishita, M et al. (2000) Interferon-gamma induces AT(2) receptor expression in fibroblasts by Jak/STAT pathway and interferon regulatory factor-1. Circ Res 86:233-40
|
|
Akishita, M; Iwai, M; Wu, L et al. (2000) Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation 102:1684-9
|
|
Akishita, M; Ito, M; Lehtonen, J Y et al. (1999) Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth. J Clin Invest 103:63-71
|
|
Akishita, M; Yamada, H; Dzau, V J et al. (1999) Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor. Biochem Biophys Res Commun 261:345-9
|
|
Yamada, H; Akishita, M; Ito, M et al. (1999) AT2 receptor and vascular smooth muscle cell differentiation in vascular development. Hypertension 33:1414-9
|
|
Lehtonen, J Y; Daviet, L; Nahmias, C et al. (1999) Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis. Mol Endocrinol 13:1051-60
|
Showing the most recent 10 out of 91 publications
